SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile

This publication has 55 references indexed in Scilit:

• Binding of antipsychotic drugs to human brain receptors
  Life Sciences, 2000
• Preclinical Neurochemical and Electrophysiological Profile of 1192U90, A Potential Antipsychotic
  Neuropsychopharmacology, 1996
• Blockade of Neurotensin Receptor by SR 48692 Potentiates the Facilitatory Effect of Haloperidol on the Evoked In Vivo Dopamine Release in the Rat Nucleus Accumbens
  Journal of Neurochemistry, 1995
• Treatment of Negative Symptoms in Schizophrenia with Amisulpride
  The British Journal of Psychiatry, 1995
• Molecular biology of dopamine receptors
  Trends in Pharmacological Sciences, 1992
• Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
  Nature, 1990
• Molecular cloning and expression of the gene for a human D1 dopamine receptor
  Nature, 1990
• Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons
  Science, 1983
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973